Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy-Reference-Cited by-同舟云学术

Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy

Published:2017-06-27 Issue:1 Volume:194 Page:9-16
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Dal Pra Alan,Panje Cedric,Zilli Thomas,Arnold Winfried,Brouwer Kathrin,Garcia Helena,Glatzer Markus,Gomez Silvia,Herrera Fernanda,Kaouthar Khanfir,Papachristofilou Alexandros,Pesce Gianfranco,Reuter Christiane,Vees Hansjörg,Zwahlen Daniel Rudolf,Engeler Daniel,Putora Paul Martin

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://link.springer.com/article/10.1007/s00066-017-1172-3/fulltext.html

Reference41 articles.

1. Ward JF, Moul JW (2005) Rising prostate-specific antigen after primary prostate cancer therapy. Nat Clin Pract Urol 2(4):174–182. doi: 10.1038/ncpuro0145

2. Swanson GP, Hussey MA, Tangen CM, Chin J, Messing E, Canby-Hagino E, Forman JD, Thompson IM, Crawford ED (2007) Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 25(16):2225–2229. doi: 10.1200/JCO.2006.09.6495

3. Wiegel T, Bottke D, Steiner U, Siegmann A, Golz R, Storkel S, Willich N, Semjonow A, Souchon R, Stockle M, Rube C, Weissbach L, Althaus P, Rebmann U, Kalble T, Feldmann HJ, Wirth M, Hinke A, Hinkelbein W, Miller K (2009) Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96–02/AUO AP 09/95. J Clin Oncol 27(18):2924–2930. doi: 10.1200/JCO.2008.18.9563

4. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED (2009) Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 181(3):956–962. doi: 10.1016/j.juro.2008.11.032

5. Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 380(9858):2018–2027. doi: 10.1016/s0140-6736(12)61253-7

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy;Clinical and Translational Radiation Oncology;2023-11

2. Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era;Cancers;2022-10-10

3. Magnetic resonance-guided ultrasound hyperthermia for prostate cancer radiotherapy: an immobilization device embedding the ultrasound applicator;Journal of 3D Printing in Medicine;2022-06

4. Combined hyperthermia and radiotherapy for prostate cancer: a systematic review;International Journal of Hyperthermia;2022-03-21

5. PSMA PET/CT and radiotherapy in prostate cancer: a winning team;Clinical and Translational Imaging;2022-01-31